No Prescription |
 |
 | ||
|
GINETTE 35 Diane 35 |
|
| ||
No Prescription » Prescription Drugs 8 » GINETTE 35 Diane 35 Cyproterone/Ethinyl estradiol is a contraceptive pill that doubles as a very effective acne treatment.Cyproterone/Ethinyl estradiol provides contraceptive protection as reliable as other pills while it also relieves acne greasy skin and hairy skin.Essentially Cyproterone/Ethinyl estradiol works by regulating your hormones: estrogen and progestogen (reproductive hormones) and androgen (which can cause acne by prompting excess oil production in your skin). With Cyproterone/Ethinyl estradiol you have the unique combined benefit of contraception and anti-acne treatment. This two-in-one solutions package solves two of your concerns at one go.With Cyproterone/Ethinyl estradiol you may also experience regular lighter and less painful periods. Discover the power of Ginette to make life easier and more enjoyable.Cyproterone/Ethinyl estradiol meanwhile contains two female hormones estrogen and progestin. These are similar to the natural hormones women produce in their ovaries. The pituitary gland is not able to distinguish the hormones contained in Cyproterone/Ethinyl estradiol from those produced by the ovaries. It therefore stops inducing the natural hormone production by the ovaries and eventually the process of egg growth and release. This hormonal feedback mechanism is based on the same principle which blocks the maturation and release of further eggs during pregnancy. Buy GINETTE 35 Diane 35 and other Prescription Drugs 8 products online at Medstore. 946
About GINETTE 35 Diane 35: Product Type: Prescription Drugs 8 GINETTE 35 ( Diane 35 Generic Ethinylestradiol/Cyproterone ) GINETTE 35 (Diane 35 Generic Ethinylestradiol/Cyproterone) Diane 35 Generic Ethinylestradiol/Cyproterone 0.035 mg + 2 mg 84 (3 x 28) Diane 35 Generic Ethinylestradiol/Cyproterone GINETTE 35
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
